Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant Women

NCT03718104 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT03718104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03718104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy, Pharmacokinetics, and Pharmacogenomics of Extended-Release Naltrexone in Pregnant Women
Lead sponsor
Boston Medical Center
Phase
Observational
Overall status
Completed
Start date
December 1, 2018
Completion date
May 8, 2024
Enrollment
46 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, neonatal abstinence syndrome, opioid-use disorder, pregnancy, high risk